Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT

L Evangelista, M Burei, AR Cervino, P Reccia… - 2018 - Soc Nuclear Med
1691 Objectives: ACKGROUND. The aim of present study was to assess the role of 18F-
FDOPA PET/CT in patients who had a suspicious forrecurrent low and high grade glioma but …

Inter comparison of 18F-FDOPA PET-CT, 99mTc-GHA SPECT-CT and 18F-FDG PET-CT in cases with recurrent glioma

K Sellam, C Bal, D Gupta, A Malhotra, A Kumar… - 2010 - Soc Nuclear Med
72 Objectives Purpose of this study was to compare the role of 18F-FDOPA PET-CT
(FDOPA), 99mTc-GHA SPECT-CT (GHA) and 18F-FDG PET-CT (FDG) in detecting …

Can 18F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study

S Karunanithi, P Sharma, A Kumar, DK Gupta… - European journal of …, 2014 - Elsevier
Purpose of the present study was to evaluate the role of 18 F-FDOPA PET/CT for predicting
survival in patients with suspected recurrent glioma. Methods A total of 33 previously treated …

Comparison between 18f-Dopa and 18f-Fet pet/Ct in patients with suspicious recurrent high grade glioma: a literature review and our experience

L Evangelista, L Cuppari, L Bellu… - Current …, 2019 - ingentaconnect.com
Purposes: The aims of the present study were to: 1-critically assess the utility of L-3, 4-
dihydroxy-6-18Ffluoro-phenyl-alanine (18F-DOPA) and O-(2-18F-fluoroethyl)-L-tyrosine …

The diagnostics of recurrent gliomas using FDG-PET: still questionable?

O Belohlávek, J Klener, J Vymazal… - Nuclear Medicine …, 2002 - journals.viamedica.pl
BACKGROUND: For a number of years, FDG-PET was considered as a gold standard for the
differential diagnosis of recurrent glioma and radionecrosis. Recently published papers …

Prognostic value of 18F-FDOPA PET in treated low-grade gliomas with non-enhancing T2 changes on MRI

A Rangan, J Czernin, T Cloughesy, A Lai… - 2013 - Soc Nuclear Med
359 Objectives Patients with previously treated low-grade gliomas often present with T2
changes on MRI without contrast enhancement. It is challenging to distinguish between …

F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI

A Santra, R Kumar, P Sharma, C Bal, A Kumar… - European journal of …, 2012 - Elsevier
PURPOSE: The purpose of the study was to compare the efficacies of FDG PET-CT and
contrast enhanced MRI in detection of recurrent gliomas. METHODS: Ninety …

18F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility

M Gómez-Río, N Testart Dardel… - European journal of …, 2015 - Springer
Purpose The follow-up of treated low-grade glioma (LGG) requires the evaluation of subtle
clinical changes and MRI results. When the result is inconclusive, additional procedures are …

18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT

S Karunanithi, P Sharma, A Kumar… - European journal of …, 2013 - Springer
Purpose Differentiation between recurrence and radiation necrosis in patients with glioma is
crucial, since the two entities have completely different management and prognosis. The …

Recurrent Glioma: Does Qualitative Simultaneous: 18: F-DOPA PET/mp-MRI Improve Diagnostic Workup? An Initial Experience

A Jena, S Taneja, AA Khan… - Clinical Nuclear Medicine, 2021 - journals.lww.com
Results Of the 26 patients, 21 patients were classified as recurrence and 5 as radiation
necrosis. Advanced MRI parameters (perfusion, diffusion, and spectroscopy) integrated with …